Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally. The company operates through Pharmaceutical Business and Fitness Business segments. It provides prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities. The company also provides corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. Kontafarma China Holdings Limited was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of Waranty Assets Management (Hk) Limited.
Research context
Tongfang Kontafarma Holdings Limited appears in PyInvesting’s Hong Kong Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- HKD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Tongfang Kontafarma Holdings Limited is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.
From a valuation standpoint, the stock is 85.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.2.
Tongfang Kontafarma Holdings Limited's total revenue rose by 301.5% to $711M since the same quarter in the previous year.
Its net income has dropped by 180.0% to $-49M since the same quarter in the previous year.
Finally, its free cash flow grew by 209.0% to $80M since the same quarter in the previous year.
Based on the above factors, Tongfang Kontafarma Holdings Limited gets an overall score of 4/5.